Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management

Area of Science:

• Hepatology
• Hematology
• Internal Medicine

Background:

• Cirrhosis, an end-stage liver disease, profoundly impacts the hemostatic system.
• Complex interactions between pro- and antihemostatic factors in cirrhosis remain incompletely understood.
• Coagulation disorders in cirrhosis arise from multiple factors including impaired synthesis, clearance, platelet dysfunction, and altered fibrinolysis.

Purpose of the Study:

• To review the pathogenesis of coagulopathy in cirrhosis.
• To discuss clinical presentations of coagulation disorders in liver disease.
• To highlight challenges in diagnosing and managing bleeding and thrombotic risks.

Main Methods:

• Literature review of studies on cirrhosis-associated coagulopathy.
• Analysis of the pathogenesis and clinical manifestations.
• Evaluation of diagnostic and therapeutic strategies.

Main Results:

• Cirrhosis involves intricate changes in clotting factors, inhibitors, platelets, and fibrinolysis.
• Traditional coagulation tests and transfusion strategies may not accurately reflect bleeding or thrombotic risks.
• Multiple management approaches for bleeding and thrombosis in liver disease have been investigated.

Conclusions:

• Cirrhosis-induced coagulopathy is multifactorial and complex.
• Current diagnostic and therapeutic tools may be unreliable for managing hemostatic risks.
• Further research and refined strategies are needed for optimal patient care.